Jeffery Stone - Chairman

Mr. Stone leads the Stone Group and has worked in a wide range of regulated industries and brings financial and regulatory affairs experience to the Indigo Board.

Andrew Dahlem, Ph.D. - Director

Dr. Dahlem is an Executive Vice President at Lilly Research Laboratories, and brings exceptional knowledge of the pharmacuetical industry to the Indigo Board. A successful drug discovery and development researcher, Dr. Dahlem has specific expertise in Drug Disposition and Toxicology.

Sangte Kim, Ph.D. - Director

Prof. Kim is the Donald W. Feddersen Distinguished Professor of Mechanical Engineering and Chemical Engineering at Purdue University, and has held executive positions within Information Technology departments at Eli Lilly, Warner-Lambert and Pfizer.